Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA424266
Max Phase: Preclinical
Molecular Formula: C20H31N3OS
Molecular Weight: 361.56
Molecule Type: Small molecule
Associated Items:
ID: ALA424266
Max Phase: Preclinical
Molecular Formula: C20H31N3OS
Molecular Weight: 361.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(N2CCN(CCCCN3CSC(C)(C)C3=O)CC2)c1
Standard InChI: InChI=1S/C20H31N3OS/c1-17-7-6-8-18(15-17)22-13-11-21(12-14-22)9-4-5-10-23-16-25-20(2,3)19(23)24/h6-8,15H,4-5,9-14,16H2,1-3H3
Standard InChI Key: SKMMUQAPKODBNV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 361.56 | Molecular Weight (Monoisotopic): 361.2188 | AlogP: 3.21 | #Rotatable Bonds: 6 |
Polar Surface Area: 26.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.22 | CX LogP: 3.35 | CX LogD: 2.47 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.73 | Np Likeness Score: -1.28 |
1. Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R.. (1996) Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate., 39 (20): [PMID:8831770] [10.1021/jm960268u] |
Source(1):